← Eichor
Study identifier: NCT06617741 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Myasthenia Gravis Foundation of America Global MG Patient Registry

Condition: Myasthaenia Gravis · Myasthenia · Myasthenia Gravis Associated with Thymoma  ·  Sponsor: Myasthenia Gravis Foundation of America

PhaseN/A
Planned participants3800
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it aims to answer are: * How and when are people with MG diagnosed? * What are the most common symptoms associated with MG? * What treatments are being used to treat MG? * What are the impacts of MG on activities of daily living, employment and quality of life? * What are the experiences with exacerbation, hospitalization and healthcare access for people with MG? Participants will answer a survey to enroll in the study, and be invited to fill out an update survey twice a year.

This description comes directly from the study's public registry record.

Talk to the study team

National Director, Patient Registry  ·  8005415454  ·  gmvalo@myasthenia.org

Always discuss trial participation with your own doctor first.

Locations (1)

Myasthenia Gravis Foundation of AmericaWestborough, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06617741